Literature DB >> 31748414

Evolved resistance to partial GAPDH inhibition results in loss of the Warburg effect and in a different state of glycolysis.

Maria V Liberti1,2, Annamarie E Allen3, Vijyendra Ramesh3, Ziwei Dai3, Katherine R Singleton3, Zufeng Guo4, Jun O Liu4, Kris C Wood3, Jason W Locasale3.   

Abstract

Aerobic glycolysis or the Warburg effect (WE) is characterized by increased glucose uptake and incomplete oxidation to lactate. Although the WE is ubiquitous, its biological role remains controversial, and whether glucose metabolism is functionally different during fully oxidative glycolysis or during the WE is unknown. To investigate this question, here we evolved resistance to koningic acid (KA), a natural product that specifically inhibits glyceraldehyde-3-phosphate dehydrogenase (GAPDH), a rate-controlling glycolytic enzyme, during the WE. We found that KA-resistant cells lose the WE but continue to conduct glycolysis and surprisingly remain dependent on glucose as a carbon source and also on central carbon metabolism. Consequently, this altered state of glycolysis led to differential metabolic activity and requirements, including emergent activities in and dependences on fatty acid metabolism. These findings reveal that aerobic glycolysis is a process functionally distinct from conventional glucose metabolism and leads to distinct metabolic requirements and biological functions.
© 2020 Liberti et al.

Entities:  

Keywords:  Warburg effect; cancer; glucose metabolism; glyceraldehyde-3-phosphate dehydrogenase GAPDH; glycolysis; mass spectrometry (MS); metabolic regulation; metabolic reprogramming; metabolomics; oxidative metabolism

Mesh:

Substances:

Year:  2019        PMID: 31748414      PMCID: PMC6952593          DOI: 10.1074/jbc.RA119.010903

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  42 in total

Review 1.  Metabolic control analysis of glycolysis in trypanosomes as an approach to improve selectivity and effectiveness of drugs.

Authors:  B M Bakker; H V Westerhoff; F R Opperdoes; P A Michels
Journal:  Mol Biochem Parasitol       Date:  2000-02-25       Impact factor: 1.759

Review 2.  Rethinking glycolysis: on the biochemical logic of metabolic pathways.

Authors:  Arren Bar-Even; Avi Flamholz; Elad Noor; Ron Milo
Journal:  Nat Chem Biol       Date:  2012-05-17       Impact factor: 15.040

3.  High Glucose Triggers Nucleotide Imbalance through O-GlcNAcylation of Key Enzymes and Induces KRAS Mutation in Pancreatic Cells.

Authors:  Chun-Mei Hu; Sui-Chih Tien; Ping-Kun Hsieh; Yung-Ming Jeng; Ming-Chu Chang; Yu-Ting Chang; Yi-Ju Chen; Yu-Ju Chen; Eva Y-H P Lee; Wen-Hwa Lee
Journal:  Cell Metab       Date:  2019-03-07       Impact factor: 27.287

4.  The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth.

Authors:  Heather R Christofk; Matthew G Vander Heiden; Marian H Harris; Arvind Ramanathan; Robert E Gerszten; Ru Wei; Mark D Fleming; Stuart L Schreiber; Lewis C Cantley
Journal:  Nature       Date:  2008-03-13       Impact factor: 49.962

5.  A strategy for sensitive, large scale quantitative metabolomics.

Authors:  Xiaojing Liu; Zheng Ser; Ahmad A Cluntun; Samantha J Mentch; Jason W Locasale
Journal:  J Vis Exp       Date:  2014-05-27       Impact factor: 1.355

6.  Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is pyruvylated during 3-bromopyruvate mediated cancer cell death.

Authors:  Shanmugasundaram Ganapathy-Kanniappan; Jean-Francois H Geschwind; Rani Kunjithapatham; Manon Buijs; Josephina A Vossen; Irina Tchernyshyov; Robert N Cole; Labiq H Syed; Pramod P Rao; Shinichi Ota; Mustafa Vali
Journal:  Anticancer Res       Date:  2009-12       Impact factor: 2.480

Review 7.  Understanding the Warburg effect: the metabolic requirements of cell proliferation.

Authors:  Matthew G Vander Heiden; Lewis C Cantley; Craig B Thompson
Journal:  Science       Date:  2009-05-22       Impact factor: 47.728

Review 8.  Cancer drug resistance: an evolving paradigm.

Authors:  Caitriona Holohan; Sandra Van Schaeybroeck; Daniel B Longley; Patrick G Johnston
Journal:  Nat Rev Cancer       Date:  2013-10       Impact factor: 60.716

9.  THE METABOLISM OF TUMORS IN THE BODY.

Authors:  O Warburg; F Wind; E Negelein
Journal:  J Gen Physiol       Date:  1927-03-07       Impact factor: 4.086

10.  Organization of enzyme concentration across the metabolic network in cancer cells.

Authors:  Neel S Madhukar; Marc O Warmoes; Jason W Locasale
Journal:  PLoS One       Date:  2015-01-26       Impact factor: 3.240

View more
  6 in total

Review 1.  A "Weird" Mitochondrial Fatty Acid Oxidation as a Metabolic "Secret" of Cancer.

Authors:  Zhivko Zhelev; Ichio Aoki; Dessislava Lazarova; Tatyana Vlaykova; Tatsuya Higashi; Rumiana Bakalova
Journal:  Oxid Med Cell Longev       Date:  2022-02-08       Impact factor: 6.543

2.  Acute Hypoxia Alters Extracellular Vesicle Signatures and the Brain Citrullinome of Naked Mole-Rats (Heterocephalus glaber).

Authors:  Stefania D'Alessio; Hang Cheng; Liam Eaton; Igor Kraev; Matthew E Pamenter; Sigrun Lange
Journal:  Int J Mol Sci       Date:  2022-04-23       Impact factor: 6.208

3.  Shikonin inhibits the Warburg effect, cell proliferation, invasion and migration by downregulating PFKFB2 expression in lung cancer.

Authors:  Liying Sha; Zhiqiang Lv; Yujun Liu; Yun Zhang; Xin Sui; Teng Wang; Hui Zhang
Journal:  Mol Med Rep       Date:  2021-06-10       Impact factor: 2.952

4.  Disruption of the Complex between GAPDH and Hsp70 Sensitizes C6 Glioblastoma Cells to Hypoxic Stress.

Authors:  Marina A Mikeladze; Elizaveta A Dutysheva; Victor G Kartsev; Boris A Margulis; Irina V Guzhova; Vladimir F Lazarev
Journal:  Int J Mol Sci       Date:  2021-02-03       Impact factor: 5.923

5.  Ginkgolide A Participates in LPS-Induced PMVEC Injury by Regulating miR-224 and Inhibiting p21 in a Targeted Manner.

Authors:  Zhonglin Liu; Yan Yang
Journal:  Contrast Media Mol Imaging       Date:  2022-09-10       Impact factor: 3.009

Review 6.  Glyceraldehyde-3-phosphate Dehydrogenase is a Multifaceted Therapeutic Target.

Authors:  Vladimir F Lazarev; Irina V Guzhova; Boris A Margulis
Journal:  Pharmaceutics       Date:  2020-05-02       Impact factor: 6.321

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.